JPWO2021123050A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021123050A5
JPWO2021123050A5 JP2022538266A JP2022538266A JPWO2021123050A5 JP WO2021123050 A5 JPWO2021123050 A5 JP WO2021123050A5 JP 2022538266 A JP2022538266 A JP 2022538266A JP 2022538266 A JP2022538266 A JP 2022538266A JP WO2021123050 A5 JPWO2021123050 A5 JP WO2021123050A5
Authority
JP
Japan
Prior art keywords
peptides
certain embodiments
parent
cooh
life
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022538266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509383A (ja
Publication date
Priority claimed from EP19218611.2A external-priority patent/EP3838912A1/en
Application filed filed Critical
Publication of JP2023509383A publication Critical patent/JP2023509383A/ja
Publication of JPWO2021123050A5 publication Critical patent/JPWO2021123050A5/ja
Pending legal-status Critical Current

Links

JP2022538266A 2019-12-20 2020-12-17 レトロインベルソペプチド Pending JP2023509383A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19218611.2 2019-12-20
EP19218611.2A EP3838912A1 (en) 2019-12-20 2019-12-20 Retro-inverso peptides
PCT/EP2020/086868 WO2021123050A1 (en) 2019-12-20 2020-12-17 Retro-inverso peptides

Publications (2)

Publication Number Publication Date
JP2023509383A JP2023509383A (ja) 2023-03-08
JPWO2021123050A5 true JPWO2021123050A5 (zh) 2023-12-06

Family

ID=69061067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022538266A Pending JP2023509383A (ja) 2019-12-20 2020-12-17 レトロインベルソペプチド

Country Status (9)

Country Link
US (1) US20230391842A1 (zh)
EP (2) EP3838912A1 (zh)
JP (1) JP2023509383A (zh)
KR (1) KR20220117319A (zh)
CN (1) CN114846020B (zh)
AU (1) AU2020409569A1 (zh)
BR (1) BR112022011906A2 (zh)
CA (1) CA3165091A1 (zh)
WO (1) WO2021123050A1 (zh)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE102006004612A1 (de) * 2006-02-01 2007-08-16 Ralf Dr. med. Jochem Therapeutische Zusammensetzung zur Vorbeugung und Bekämpfung von Knochenmetastasen
ES2352205T3 (es) 2005-12-14 2011-02-16 Licentia Ltd. Usos de una proteína del factor neurotrófico.
EP2271358B1 (en) * 2008-03-25 2018-11-21 Amarantus Therapeutics, Inc. use of mesencephalic astrocyte-derived neurotrophic factor for treating Parkinson's disease
FI20080326A0 (fi) 2008-04-30 2008-04-30 Licentia Oy Neurotroofinen tekijä MANF ja sen käytöt
US8906355B2 (en) * 2009-10-29 2014-12-09 Lucia Irene Gonzalez Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
CN103987400B (zh) * 2011-06-09 2019-09-13 迈阿密大学 治疗视网膜疾病的方法
FI20115870A0 (fi) 2011-09-05 2011-09-05 Urmas Arumaee Neuroprotektiiviset soluihin tunkeutuvat peptidit
DK2864360T3 (en) * 2012-06-25 2017-12-18 Brigham & Womens Hospital Inc TARGETED THERAPY
EP3377089B1 (en) * 2015-11-18 2020-04-08 Herantis Pharma Plc Compositions comprising cdnf for use in the intranasal treatment of central nervous system diseases
EP3454885A4 (en) * 2016-05-12 2019-12-25 Ohio State Innovation Foundation PEPTIDES AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
EP3619227A1 (en) 2017-05-04 2020-03-11 Helsingin Yliopisto C-terminal cdnf and manf fragments, pharmaceutical compositions comprising same and uses thereof

Similar Documents

Publication Publication Date Title
US5710245A (en) Alpha-helix mimetics and methods relating thereto
HUT75708A (en) Neurokinine (tachykinine) antagonists
DE3784799D1 (de) Malonsaeurederivate und ihre synthesemethoden.
TR200200252T2 (tr) Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı
JP2021501201A5 (zh)
RU2014130446A (ru) Дипептид, содержащий непротеиногенную аминокислоту
IE62213B1 (en) Methods and compositions for preparation of h-arg-x-z-y-tyr-r
ATE280827T1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
CN101072791B (zh) 固相合成中的s-烷基-硫基保护基团
JPWO2021123050A5 (zh)
JP2021506815A5 (zh)
US5079231A (en) Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them
HUP0401535A2 (hu) Szomatosztatin antagonisták és alkalmazásuk
HUP0301396A2 (hu) Integrin inhibitor hatású peptid- és peptidutánzó konjugátumok, azokat tartalmazó implantátumok és alkalmazásuk
CN1119650A (zh) 具有胃肠道运动刺激活性的胃动素样多肽
TW200505943A (en) Polypeptide
DE602004024593D1 (de) Verfahren zur herstellung von peptiden
JPH04502908A (ja) アミノ酸のトリアルキルシリルエステルおよびペプチド合成におけるその使用
FR2837837B1 (fr) Epitopes peptidiques communs a des antigenes d'une meme famille multigenique
JP2005532996A5 (zh)
JP2005532996A (ja) ヘプタペプチドオキシトシンアナログを製造するための中間体及び方法
US3503951A (en) Complexes of a.c.t.h. peptides with polyglutamic and polyaspartic acid
Ghosh et al. One pot amide/peptide synthesis via two redox reactions
Niebler et al. The amino acid sequence of the L-glutamic acid containing mureins of Micrococcus luteus and M. freudenreichii
Gregory et al. Polypeptides. Part VII. Variations of the phenylalanyl position in the C-terminal tetrapeptide amide sequence of the gastrins